| Zhang, Hongqi |
| Terminated | N/A | 11 | RoW | Surpass Streamline Flow Diverter System | Stryker Neurovascular, Stryker (Beijing) Healthcare Products Co., Ltd | Aneurysm, Intracranial | 09/23 | 09/23 | | |
NCT06158750: To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms |
|
|
| Recruiting | N/A | 120 | RoW | p64/p48 MW HPC Flow Modulation Device | Shanghai Wallaby Medical Technologies Co.,Inc., Phenox GmbH, Beijing Wallaby Medical Technologies Co.,Inc. | Intracranial Aneurysm | 02/26 | 06/26 | | |
| Recruiting | N/A | 500 | RoW | Surpass Evolve Flow Diverter System | Stryker Neurovascular, Stryker (Beijing) Healthcare Products Co., Ltd | Intracranial Aneurysm | 11/27 | 08/31 | | |
NCT05774782: Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification |
|
|
| Active, not recruiting | N/A | 14 | RoW | Cerebral flow diverter | Sinomed Neurovita Technology Inc., Xuanwu Hospital, Beijing | Cerebral Aneurysm, Cerebral Aneurysm Unruptured | 01/25 | 01/25 | | |
| Hu, Peng |
| Active, not recruiting | 4 | 640 | RoW | Tenofovir Amibufenamide（TMF）, HS-10234 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Hepatitis B, Chronic | 06/24 | 09/29 | | |
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection |
|
|
| Completed | 2 | 250 | RoW | GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table | Sunshine Lake Pharma Co., Ltd. | Chronic HBV Infection | 06/22 | 09/23 | | |
| Recruiting | 2 | 116 | RoW | Placebo, TQA3334 Tablet, Nucleoside (acid) analogs (NAs) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Hepatitis B | 12/25 | 06/26 | | |
NCT06452693: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B |
|
|
| Not yet recruiting | 1/2 | 162 | RoW | TQA3038 injection/placebo, Nucleotide drugs Control group | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Hepatitis B, Chronic | 09/26 | 09/26 | | |
NCT05755776: The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment |
|
|
| Recruiting | N/A | 204 | RoW | TMF, Heng Mu | The Second Affiliated Hospital of Chongqing Medical University, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Chronic Hepatitis B | 12/24 | 12/24 | | |
| Zhang, Yuqing |
NCT06632262: A Phase 2 Clinical Study of ABSK061 and ABSK043 |
|
|
| Not yet recruiting | 2 | 202 | RoW | ABSK061 + ABSK043, ABSK061+ABSK043 in combination with CAPOX | Abbisko Therapeutics Co, Ltd | HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Solid Tumors | 11/29 | 06/30 | | |
NCT05997667: Study on the Efficacy and Safety of Rechargeable Implantable DBS System in the Treatment of Parkinson's Disease |
|
|
| Recruiting | N/A | 60 | RoW | Rechargeable implantable deep brain stimulation system | Lepu Medical Technology (Beijing) Co., Ltd. | Parkinson Disease | 01/25 | 07/25 | | |
| Li, Jiping |
NCT06439381: Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps |
|
|
| Recruiting | 2 | 120 | RoW | 300mg/600mg of TQH2722 injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Rhinosinusitis | 10/25 | 11/25 | | |
NCT06089278: A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps. |
|
|
| Recruiting | 2 | 160 | RoW | 300mg of TQH2722 injection, 600mg of TQH2722 injection, TQH2722 injection matching placebo | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Sinusitis | 05/25 | 05/25 | | |
NCT06346899: A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China |
|
|
| Recruiting | N/A | 130 | RoW | No intervention | Takeda | Hereditary Angioedema (HAE) | 08/25 | 08/25 | | |
| Ren, Liankun |
| No trials found |
